Description
Key Indications
- Integrated Peptides BPC-157 Pure: BPC-157 (Body Protection Compound-157) is a peptide made up of 15 amino acids, derived from a protective protein found in the stomach. It’s known for its regenerative capabilities
Key Indications:
- Musculoskeletal Injuries: Promotes faster wound healing and enhances recovery from tendon, ligament, and muscle injuries.
- Gut Health: Promote healing of gastrointestinal issues like ulcers, IBD, and leaky gut and maintain gut integrity.
- Chronic inflammation and soft tissue damage: Manage inflammation-related conditions, providing relief from pain and swelling.
- NSAID-induced toxicity and liver damage
- Joint, bone, and connective tissue degeneration
- Cardiovascular issues: Support heart health by promoting blood vessel formation and improve circulation.
- Neurological damage: Promotes neuroprotection and helps in recovery from neurological impairments.
Recommended dosage:
Take 1 capsule once daily, on an empty stomach, or as directed by your healthcare provider.
Why Choose This Product?
- Faster Absorption: This Integrative Peptides BPC-157 offers faster absorption for more immediate therapeutic effect.
- Ideal for acute injury, inflammation, and post-surgical recovery.
- High Purity and Bioavailability: Integrative Peptides offers a high-purity form of BPC-157, ensuring effective absorption and utilization by the body. The capsules are designed for quick absorption, providing rapid delivery of the peptide’s benefits.
- Convenient Administration: The capsule form allows for easy oral administration, eliminating the need for injections and simplifying the supplementation process.
- Multi-system Healing Support: Beyond musculoskeletal benefits, it supports multiple bodily systems, including gastrointestinal, neurological, and cardiovascular, offering a holistic approach to health.
FAQs
BPC-157 is a synthetic peptide composed of 15 amino acids, derived from a naturally occurring protective compound found in human gastric juice. It has been extensively researched for its healing, anti-inflammatory, and organ-protective properties, particularly for the gastrointestinal tract, musculoskeletal system, and brain.
Not necessarily better—just different. If a quick onset is required, Immediate Release is the best option. For GI health or situations where gradual absorption is required, delayed release is more appropriate.
Yes. BPC-157 has demonstrated no toxicity in animal or human trials. It is highly stable in gastric juice, does not require a carrier, and has no reported side effects.
Currently, no adverse drug interactions have been reported with BPC-157. But you should always inform your healthcare provider about all medications and supplements you’re using.
People who are recovering from tendon, ligament, or muscle injuries, with persistent gut disorders (IBD, ulcers, leaky gut), inflammation or tissue damage from NSAIDs, wanting speedier surgery or injury recovery, managing brain-gut dysfunction or systemic inflammation.
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of applied physiology. 2011 Mar;110(3):774-80.
- Sikiric P, Seiwerth S, Rucman R, Turkovic B, Stancic Rokotov D, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current pharmaceutical design. 2011 Jun 1;17(16):1612-32.
- Ilic S, Drmic D, Franjic S, Kolenc D, Coric M, Brcic L, Klicek R, Radic B, Sever M, Djuzel V, Filipovic M. Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions. Life sciences. 2011 Mar 14;88(11-12):535-42.
- Sikiric P, Sever M, Krezic I, Vranes H, Kalogjera L, Smoday IM, Vukovic V, Oroz K, Coric L, Skoro M, Kavelj I, Zubcic S, Sikiric S, Beketic Oreskovic L, Oreskovic I, Blagaic V, Brcic K, Strbe S, Staresinic M, Boban Blagaic A, Skrtic A, Seiwerth S. New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotection. Inflammopharmacology. 2024 Oct;32(5):3119-3161. doi: 10.1007/s10787-024-01499-8. Epub 2024 Jul 9. PMID: 38980576.
